Trials / Recruiting
RecruitingNCT07174115
A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps
A Phase IIa Clinical Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to assess the efficacy and safety of HTMC0658 tablets in treating subjects with chronic rhinosinusitis without nasal polyps (CRSsNP).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HTMC0658 | HTMC0658 tablet |
Timeline
- Start date
- 2025-08-18
- Primary completion
- 2026-04-01
- Completion
- 2026-06-01
- First posted
- 2025-09-15
- Last updated
- 2025-09-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07174115. Inclusion in this directory is not an endorsement.